111
stored articles
3 September 2021 News Archive
3 Sep 2021 13:56 GMT
Novartis discontinues phase 2 trial for kidney transplant drug candidate
Seeking Alpha
3 Sep 2021 13:56 GMT
Spok Holdings gains as company conducts strategic review after inbound interest
Seeking Alpha